Investment Pitches

Pitch Summary:
Rusoro Mining is positioned to benefit from recent U.S. policy changes regarding Venezuela. The company holds a significant claim against PDVSA, with a U.S. Court judgment of approximately $1.55 billion. Rusoro has negotiated a recovery structure that includes $400 million in cash and $650 million in convertible notes. The company's involvement in the Citgo sale further enhances its potential for financial recovery.

BSD Analysis:
Rusoro Mining's strategic alliance with Elliott in the Citgo sale positions it favorably to capitalize on the evolving geopolitical landscape. The willingness to accept a reduced settlement for immediate liquidity demonstrates a pragmatic approach to unlocking value. However, the company's Canadian domicile could pose regulatory challenges. The resolution of outstanding claims could significantly enhance Rusoro's financial standing, making it a compelling investment opportunity.

Pitch Summary:
Alibaba Group presents a strong investment case as a leading e-commerce and cloud computing company in China. The company offers a comprehensive ecosystem, including the dominant e-commerce platform, a rapidly growing cloud division, logistics through Cainiao, and a payments platform via Ant Group. Despite geopolitical risks and economic challenges in China, Alibaba's valuation at approximately 13x NTM EBITDA is attractive. The company has also been proactive in capital allocation, retiring about 15% of its shares, indicating a shift in strategy. With the potential for China equities to rebound, Alibaba stands out as a key player poised to benefit from a more favorable policy environment and market sentiment.

BSD Analysis:
Alibaba's cloud computing division, growing at 34%, is a significant driver of future revenue, particularly with AI-related sales now comprising over 20% of external cloud revenue. The company's strategic share buybacks reflect a commitment to enhancing shareholder value and confidence in its long-term prospects. While geopolitical tensions and China's economic landscape pose risks, Alibaba's diversified business model and market leadership position it well for recovery and growth. The current pessimism surrounding Chinese equities may be overblown, offering a unique opportunity for investors to capitalize on Alibaba's undervaluation and potential upside as market conditions improve.

Pitch Summary:
Shift4 Payments is a compelling investment opportunity due to its strong position in the payments processing industry, particularly in high-volume sectors like hospitality and entertainment. The company has demonstrated impressive growth, compounding at over 25% annually, and is expanding its international presence through strategic acquisitions like Global Blue. Despite recent stock price declines due to broader fintech sector pressures and tax loss harvesting, the company's fundamentals remain strong, with a valuation of approximately 7x LTM EBITDA and 5.5x 2027 FCF. Management's confidence is evident in their recent $1 billion stock buyback authorization, suggesting the stock is undervalued. I am adding to my position on price weakness, anticipating continued growth and value realization.

BSD Analysis:
Shift4 Payments' strategic acquisition of Global Blue positions it well in the European market, enhancing its capabilities in tax-free shopping and cross-border payments. The company's organic growth rate of 20% is impressive, especially in a competitive industry. The current valuation appears disconnected from the company's growth prospects, providing an attractive entry point for investors. Management's decision to authorize a significant buyback underscores their belief in the company's undervaluation and future potential. As the payments industry continues to evolve, Shift4's focus on high-volume venues and international expansion could drive substantial long-term shareholder value.

Pitch Summary:
@ManuInvests frames StoneCo as a misunderstood fintech turnaround after the stock’s collapse from prior highs tied to a poorly executed credit push and weak capital allocation. The pitch argues a 2023 CEO change triggered a strategic reset: exiting distractions, writing off bad bets, and refocusing the franchise on its core MSMB payments and financial-services ecosystem. A key catalyst is the sale of the Linx software unit, positioned as a meaningful cash infusion relative to market value despite being a small contributor to revenue and profits. The author expects shareholder-friendly capital return, highlighting buybacks and a more disciplined relaunch of credit with tighter risk controls. Operational momentum is supported by strong EPS growth and ROE metrics, suggesting improved profitability and efficiency. The bull case is that a combination of earnings compounding, aggressive buybacks, and multiple normalization can drive outsized equity returns, albeit with acknowledged LatAm risk.

BSD Analysis:
StoneCo is best underwritten as a Brazilian merchant-acquiring and financial-services platform where distribution, underwriting discipline, and operating leverage determine long-term returns. The turnaround hinges on management proving that credit can be a controlled attachment to payments rather than a balance-sheet landmine, with risk costs normalized across cycles. Divesting non-core software simplifies the story and can improve capital efficiency, but it also narrows diversification, increasing dependence on MSMB health and Brazilian macro. Competitive intensity remains high in Brazilian payments, so share retention will be driven by product breadth (banking, payments, working capital) and service quality, not just pricing. If buybacks are executed at depressed multiples while ROE stays structurally high, per-share compounding can be powerful even without heroic growth. The main risks are macro shocks, regulatory shifts, and a repeat of credit missteps that would quickly impair confidence and funding economics. Valuation upside is most durable if StoneCo demonstrates consistent earnings power through a stress period, converting “turnaround” into “quality compounder.”

Actual Post Content:
$STNE is an overlooked turnaround in Fintech. The stock is down from 2021 highs due to a failed credit program and poor capital allocation. But under a new CEO (2023), the company has made a major pivot. $STNE is setup for a potential multibagger New management team isn't just talking about re-focusing, they are executing. - Bad investments written off. - Non-core assets sold. - Re-focus on core, sticky MSMB (Micro, Small, Med Biz) ecosystem. The goal? Focus on the profitable core and maximizing shareholder returns. $STNE is divesting its non-core software business, Linx. - Giving up only 8% of Revenue / 5% of Net Income. - Selling for cash equivalent of >20% of current Market Cap. This is a massive cash injection created by shedding non-core weight. Management has guided to return all excess capital to shareholders. • Buyback Yield: >10%. • Credit: Relaunched with strict fixes from previous lessons. • Fundamentals: 37% YoY Adj. EPS growth & Core ROE >30%. Guiding for ~27% CAGR through 2027 (excluding Linx proceeds). You rarely get high growth and value in the same package. EPS Growth (27% CAGR) + Aggressive Buybacks + Multiple Re-rating = Strong Returns. $STNE is a LatAm fintech compounding through focused management and capital allocation, trading at an attractive value. Want to dive deeper? I recently m published a full research journal on $STNE covering the valuation, risks, and 2027 models. This is a premium post, but you can read it with a 7-day free trial. If you find it helpful, take advantage of the ongoing New Year Sale: 20% off. Offer ends Jan 3rd! Link in bio. Worth it imo Thank you. Great opportunity imo Yes 100% valid perspective. And for the most part I agree. There I certainly a LaTam risk factor baked in here but I think the risk/reward setup for $stne is great. But yeah - vast majority of my holdings are US/little bit of euro. Completely valid strategy to have. Risk and risk tolerance is what matters DMs gave performed exceptionally well esp considering the less risk. Can’t go wrong with that philosophy and there’s no promise out outsized returns in EM, risk materialization can wipe them out.

URL: https://x.com/ManuInvests/status/2007093201807810884

Pitch Summary:
@weary_centurion argues UiPath is being misframed as a fading RPA vendor when the market should be underwriting a much larger, long-duration platform opportunity. The core claim is that “Maestro” is the overlooked catalyst that can reignite growth and broaden relevance across many industries beyond classic automation use cases. The thesis leans heavily on leadership, portraying CEO Daniel Dines as unusually mission-driven, self-correcting, and essential to sustaining a compounding culture over decades. The author views Dines’ control and continued ownership as alignment rather than governance risk, and suggests demand signals plus re-accelerating growth through 2025 set up a 2026 confirmation year. A major valuation angle is that the stock is “priced for” a struggling narrative despite improving momentum and strong retention among large customers, implying an asymmetric rerate if execution continues. Key risks highlighted implicitly are key-man risk (selling if Dines leaves), the need for deeper diligence beyond surface metrics, and the possibility Wall Street skepticism persists until tangible proof points land. Net: a bullish, founder-led multi-year compounder setup with a near-term perception gap the author expects to close.

BSD Analysis:
UiPath’s real debate is whether automation stays a tools market or evolves into an enterprise control plane for “process + agents + governance,” where orchestration becomes the durable choke point. If Maestro genuinely unifies task mining, workflow design, run-time orchestration, security/compliance, and outcome analytics, the company can shift from seat-based RPA economics to higher-ARPU platform economics with improved attach and stickier expansion. The competitive set is more dangerous than legacy RPA peers: hyperscalers and system-of-record platforms can bundle automation (Microsoft, ServiceNow, Salesforce ecosystem) and compress standalone pricing, forcing UiPath to win on time-to-value, governance, and cross-system interoperability. The bull case requires evidence that Maestro drives net-new budgets (not just module reshuffling), with improving gross retention, multi-product penetration, and expanding operating leverage from a mostly software model. The bear case is “automation commoditizes” and Maestro becomes a feature rather than a platform, leaving UiPath stuck defending mid-market RPA while growth and multiples remain capped. Watch contract structure and mix: larger, multi-year platform commitments and services attach should show up in RPO quality, NRR durability, and margin trajectory. If those signals emerge while valuation remains anchored to a “mature RPA” narrative, the setup for multiple expansion is real; if not, the stock can stay cheap for a long time.

Actual Post Content:
Iv been searching for a potential 100x stock since I started in the stock market back in 2021 I think $PATH is a very realistic contender and probably the first stock I have found where I can see a reliable roadmap over 10-20 years Daniel Dines very much reminds me of a young Jeff Bezos He’s made all the necessary mistakes and failed enough times to become wise beyond his years UiPath has been written off by the market as a struggling RPA company with decaying growth Maestro and its potential to revolutionise multiple sectors across the world has been ignored The valuation is insulting Daniel Dines isn’t messing around He left once, realised it was the wrong move and I don’t think he will ever leave again until he retires To be a 100x you need a company which maintains its culture and does not become complacent There are plenty of 5-10x stocks that eventually come crashing back down to reality due to complacency and a lack of vision Daniel Dines is a rare breed of CEO A self critical reflector with an eye on perfection He takes his mistakes seriously and iterates his performance on a constant basis Providing he remains CEO, I am confident in his ability to drive UiPath in the required direction for success He has total control over the company Whilst some see that as a risk, I see it as a huge benefit The company started to derail once he took a back seat, for good reason Daniel lives and breathes UiPath It makes him tick and gives him purpose He is not driven by material wealth or power He is motivated only by his mission to make UiPath what he always intended it to be, a game changer He is fully focussed on the future of the company, with 20 years of experience and wisdom under his belt Daniel is 54 years old By Gods grace if he lives into his 80s, then we have perhaps 20-30 years of his stewardship I am not even sure he will retire Based on what he says, work life balance is overrated, and he does not do very well when he is not doing what he does best The company is approaching a very important infection point in relation to its growth 2025 has seen a steady trajectory of growth re-acceleration, from low single digits in Q1 to mid double digits in Q3 Daniel has stated that he has never seen such demand for Maestro since the early days of RPA To me this means that growth will continue to accelerate in 2026 and probably above expectations Daniel and the team are very modest If he is saying he’s never seen demand like it then to me that is something to take a lot of notice of Because he is not the sort of man to say this lightly The main reason I think $PATH will outperform most stocks in 2026 is because Wall Street is completely sleeping on the company At Q3 earnings, I was shocked at the lack of interest from analysts They couldn’t even be bothered to phone in, tasking their intern instead And the questions asked were insulting, failing to mask exactly what Wall St thinks of UiPath which is basically that they don’t believe what management are saying Concerns in relation to “sustainability” and a strange focus on the effects of the government shutdown as well as macro, neither of which are a concern to UiPath I was perplexed sat listening so God only knows how annoyed Dines will have been I think his response on the subsequent interview where he flat out stated that analysts are completely wrong is their assumptions covered it sufficiently Wall St don’t get it yet, but they will be forced to at some point Most people look at UiPath and write it off as a result of growth I encourage you to look again as I did thanks to @AuditTheHerd and you may see what I am talking about This is a case where surface level due diligence will reveal very little A deeper dive is required 2026 is where the thesis will likely be confirmed This is not financial advice Please do your own research and make your own decisions Thanks Davy I honestly don’t think he will ever leave If he did, I would probably sell! Watched/listened to many hours of footage/dialogue, researched his history etc One skill I have is character assessment, sometimes people are harder to weigh up, but I’m confident what you see is what you get with Daniel 113% net dollar retention rate for customers with $100K+ in ARR It is routine selling and Daniel still owns 20% of commons and 100% of preferred shares This is not mass panic selling at all and is likely part of a routine income source from SBC Revenue growth has accelerated substantially this year and will continue to next year It isn’t in a bad position at all We will see Apple didn’t fall after Steve Jobs But it became a substantially less impressive company with time following his absence It has survived off his legacy and is not what it was under his leadership CEO matters more than anything

URL: https://x.com/weary_centurion/status/2006778788399689944

Pitch Summary:
A large gain in 2024 is partly given back in 2025. Delays in getting the 34X beach, delays in getting HMS production going, diamond production going, a further fundraise, and a share price slipping back as investors lose hope mean this hasn’t been a great year for KZG. Despite the setback my profit model got some level of validation from further disclosures from KZG management and news that outsize diamonds could offer substantial upside. The arbitration award concluded successfully and enforcement continues, while interest in acquiring Aftan might end up being the wiser course of action. Lithium’s price has doubled in late 2025 and Tantalum prices remains at elevated levels.

BSD Analysis:
Kazera is a small-cap natural resources story where value is tied to asset development milestones and financing availability. Upside comes from getting projects into production or monetizing them through partnerships and sales. Downside comes from dilution and delays, which are common in small-cap resources. Investors should focus on timeline credibility, permitting, and funding runway. Commodity price swings can overwhelm execution progress. If management demonstrates disciplined steps toward cash generation, sentiment can shift quickly. Otherwise, it remains a speculative optionality vehicle.

Pitch Summary:
As I pointed out to a reader recently, FTSE100 UK banks have been on a tear in 2025 some like Natwest up 60%. But not the banks held by AUGM: Iwoca, Zopa and Tide. Yet AUGM’s banks are outpacing and outclassing the likes of Natwest and the big 4 or so. Top 5 AUGM holdings Revenue growth of 34%, Profit growth 160%. And then you have to consider other holdings like Gold Merchant BullionVault. To be down -14.2% while the NAV is down -4% in the year to 30/09/25 makes no sense to me.

BSD Analysis:
Augmentum is a listed venture portfolio focused on fintech, which means it’s effectively a bet on the next cycle of fintech IPOs and M&A. In risk-off periods, fintech multiples compress and portfolio marks get punished regardless of fundamentals. The upside is significant if a few holdings reach scale, become profitable, and find exit paths. The key risk is follow-on funding—private companies need cash, and public vehicles can be forced into dilutive raises. Investors should watch cash at the parent, concentration, and whether management can secure strategic exits. The discount to NAV is often the real battleground. This is high-duration optionality, not near-term earnings.

Pitch Summary:
TMT delivered a positive NAV return in its results to 30/06/25 up from $205m to $213m. Yet you can buy it for $83.8m. As I covered in “Oh So Juicy” its major holding Bolt.EU is undervalued compared with Uber. By my own estimates buying TMT you are buying Bolt.EU for about 15X less than what investors were paying for Uber in 2022 when Uber was at a similar stage of growth. If the IPO market improves in 2026 and Bolt is one of those this share will go nuts. There’s lots of other exciting companies it holds too.

BSD Analysis:
TT Investments is typically a capital-allocation and portfolio-performance story, where returns depend on security selection, fees, and realizing value rather than operating growth. Vehicles like this can trade at wide discounts due to opacity and investor skepticism. Upside comes from closing the discount through buybacks, realizations, or improved performance. Downside comes from illiquidity, mark risk, and inconsistent returns. Investors should focus on NAV trend, liquidity, and governance. If management is shareholder-aligned, discounts can compress meaningfully. If not, it stays cheap forever.

Pitch Summary:
Up is good, but it’s barely up. Considering Uranium is now $83/Lb Spot and higher for Term, considering Copper is $12,400 tonne. Considering POW appear to be planning buy backs or some sort of capital return in 2026, considering it now has some valuable Royalties, a Blockchain Mining Funding Venture, and numerous listed project holdings including FDR, AAJ, FCM and free carries on other projects it is a bit perplexing this is up only 0.8%. I anticipate this madness will end and it will rerate in 2026, as newsflow from POW continues to build confidence.

BSD Analysis:
Power Metal is an exploration-stage resources vehicle, meaning the investment case is almost entirely optionality and deal flow. Upside comes from discovery, farm-outs, or asset sales that validate geology and attract capital. Downside comes from dilution and the reality that most exploration doesn’t become a mine. Investors should evaluate management credibility, project quality, and whether the company can monetize assets rather than endlessly drill. Commodity cycles heavily influence funding availability and sentiment. This is not cash-flow investing; it’s portfolio-style speculation. If you own it, you’re underwriting optionality and capital markets.

Pitch Summary:
IP Group completed their buy back program and a major holding Hinge Health is up 40% since its IPO in May 2025. ONT reformed its guidance and its shares are flat in 2025 but the outlook remains good. IPO remains a holding with numerous shots on goal within its bioscience holdings and green tech holdings so am happy to hold.

BSD Analysis:
IP Group is a listed venture capital model focused on university spinouts and deep tech, where outcomes are driven by a handful of winners. In risk-on markets, NAV uplifts and exits can look magical; in risk-off markets, discounts widen and liquidity disappears. The core question is whether the portfolio contains real category winners that can mature into high-value exits. Investors should focus on cash runway at the parent and the funding needs of key holdings. The best case is a few realizations that validate marks and fund buybacks, shrinking the discount. The worst case is perpetual “paper value” with continuous dilution. This is optionality packaged as a public equity.

Pitch Summary:
Petrotal got a beating for pulling its chunky dividend and suffered a series of setbacks with leaks, pump failures, water handling issues, an unsuccessful workover, drilling rig delays and softer oil prices. I covered this in “Flower Again” and with PTAL at well below 50% of its 1P NAV let alone the prospectivity of its 2P and 3P resources it is at a bargain price if it can sort out its issues and get back on the prize. If I’m right about Oil prices too then this could multi bag in 2026 from here.

BSD Analysis:
PetroTal is a focused E&P with exposure to Peru, offering meaningful leverage to oil prices with a relatively concentrated asset base. The upside is strong cash generation when operations run smoothly and export routes remain stable. The downside is political and social risk—community relations, permitting, and government policy can impact production and economics. Capital discipline is central: investors want returns, not empire-building. Currency and tax/regulatory changes can shift the cash flow profile quickly. If management maintains stable operations and prioritizes shareholder returns, valuation can improve. PetroTal is a high-torque producer where country risk is the main discount.

Pitch Summary:
I remain robustly positive on the outlook for DEC. US Nat Gas fell to $3.80/mmbtu but was well above $4.00 throughout the last few months and growing levels of LNG and growing needs of energy for Data Centres position DEC well for 2026. DEC acquired Canvas in November and issued 3.1m shares as part of that deal. As at 31/12/25 it has ALREADY bought back 2m of those 3.1m shares and shares in issue stand at 79m (and falling). I look forward to the 4Q25 results and indeed to 2026 and beyond.

BSD Analysis:
Diversified Energy is a natural gas cash-flow story built on acquiring mature, long-life assets and managing declines efficiently. The model works when the company can buy production cheaply, optimize costs, and hedge intelligently. The risk is that legacy wells come with environmental liabilities and higher-than-expected maintenance capex, which can erode free cash flow. Leverage and hedging policy matter because gas prices are volatile and refinancing windows can close. If execution is disciplined, the company can generate strong cash yield. If costs creep or liabilities rise, the equity de-rates quickly. This is a “cash today, questions tomorrow” trade unless disclosures and liability management are rock solid.

Pitch Summary:
You can currently buy Fair at a 6.5% discount at $0.47, and the latest NAV is $0.5039. Fair has positioned heavily into European CLOs and has large cushions far in excess of either the default rate or even the distress ratio. In other words you would need a substantial worsening in credit markets to be at the risk of loss of capital. FAIR is buying back its own shares since the point of its CLOs are that they are highly cash generative. FAIR pays out $0.02 per quarter, you see, which on $0.47 is a 16.7% yield. Next one goes ex dividend in early Feb and is paid around 7th March 2026.

BSD Analysis:
Fair Oaks Income is a structured credit vehicle where returns are driven by spreads, defaults, and leverage discipline. In benign credit environments, these products can deliver attractive yield with seemingly low volatility. In stressed environments, correlations jump and marks can get ugly fast. The key is understanding underlying collateral quality and the manager’s track record through downturns. Investors should watch NAV stability, distribution coverage, and leverage structure. The upside comes from harvesting illiquidity and complexity premia. The downside is that complexity can hide risk until it doesn’t.

Pitch Summary:
ANIC remains at a 50% discount to NAV and while certain holdings have gone bust in 2025, others are flourishing. BlueNalu is one. Blue Fin Tuna has an extremely high ticket price and serious ethical issues given the critically-endangered status - it makes sense to make this stuff, even if it’s expensive to make. A KG of Blue Fin flesh sells for over $1m. ANIC invested a further $6m yesterday, actually, and holds 12.96%. 2026 is the year for US regulatory engagement and commercial launch. It has an agreement with Nomad Foods (Europe’s largest frozen food co) and others.

BSD Analysis:
Agronomics is a venture-style listed vehicle focused on cultivated meat and cellular agriculture, meaning it’s long-duration optionality with a high burn-rate ecosystem. The upside is enormous if even a few portfolio companies break through on cost curves, regulation, and consumer acceptance. The downside is that timelines are long, financing is cyclical, and dilution is common across the space. Valuation will swing with risk appetite more than near-term fundamentals. Investors should focus on portfolio quality, follow-on funding capacity, and whether any holdings are reaching commercialization milestones. This is not a conservative investment—it’s a thematic bet on a potential food-tech shift. If the theme goes cold, discounts can persist for years.

Pitch Summary:
I last wrote about CGEO in “CGEO positioning” to cover the full year results to 31/12/24. The NAV at that point was £27.14 per share. Today it’s £41.47. Shares were 37.6m today they are 33.6m today through continuing buy backs. The share remains at a 24.5% discount despite a storming performance in 2025. Yes the share has risen 160% but remains very attractive where the private businesses are valued at only 7.1X to 9.9X earnings. Brokers forecast double digit growth for 50% of CGEO which is BGEO (also up 99% YTD). It remains in the OB stable for 2026.

BSD Analysis:
Georgia Capital is a holding company exposure to the Georgian economy, blending financial services, healthcare, real estate, and other domestic assets. The bull case is that Georgia is underpenetrated in many sectors, enabling above-average growth for well-capitalized local champions. The bear case is country risk: currency volatility, politics, and liquidity can overwhelm fundamentals. Conglomerate discounts are typical, and value realization often requires active capital allocation like buybacks or asset sales. Investors should focus on transparency, governance, and whether management is shrinking the discount over time. If macro stability holds, the sum-of-the-parts can be meaningfully undervalued. If macro turns, the discount can widen regardless of execution.

Pitch Summary:
The most recent addition is Ascentech K.K.. Listed in the Tokyo Stock Exchange, Ascentech is the first Japanese stock in your manager’s career. Ascentech caught your manager's attention when it elevated its business model in March 2025. Before March 2025, Ascentech was a tier-1 distributor and systems integrator (SI) for Citrix. It bought Citrix licenses wholesale which were sold to other SIs and enterprise clients. After March 2025, Ascentech became the Citrix operator in Japan. Revenue-share with higher margins (25-35% gross margins) replaces fixed distributor margins (8-15%). Multi-year recurring subscriptions reduce working capital risk. Access to the entire slate of Citrix products and bundling opportunities increase revenue growth potential. However, the transformation entailed upfront payments (tied to projected sales) payable to the Citrix parent. Missing projected sales is an obvious risk. What may cause a miss in sales are Ascentech missing on execution and poor demand for Citrix products. Your manager is comfortable with Ascentech’s execution. It has demonstrated world-class competence in Japan (~19% ROE, ~38% ROIC over past decade) for it to become an operator. For the other risk, Citrix is one of two leaders in VDI (Virtual Desktop Infrastructure). The post-pandemic hybrid work tailwind is unlikely to dissipate. Risk-averse customers in the highly-regulated industries (city governments, finance, healthcare) that Ascentech targets are unlikely to abandon hybrid work arrangements, even with back-to-office mandates. The demand for more secure and efficient hybrid work will only increase. AI is also unlikely to disrupt Citrix like it may for other software. Citrix is the control-plane infrastructure within which AI runs. The stock has risen 70% over the past year but it’s still trading at forward multiples (9.5x PBT and 13.5x PE) that seem to undervalue its position as the exclusive operator of leading VDI software.

BSD Analysis:
Ascentech operates in Japan’s enterprise IT ecosystem, focusing on infrastructure and system integration where reliability and long-term relationships matter more than rapid growth. Demand is driven by ongoing digital transformation, cloud migration, and cybersecurity needs among conservative corporate customers who prioritize execution over experimentation. The business benefits from recurring service and maintenance revenue, which stabilizes cash flow despite project-based lumpiness. Growth tends to be incremental rather than explosive, reflecting Japan’s mature IT spending environment. Margin performance hinges on utilization rates and labor cost control, as talent availability is a persistent constraint. Balance-sheet conservatism reduces downside risk but can limit aggressive expansion. Ascentech is best viewed as a steady operator positioned to compound quietly if it continues climbing the value chain toward higher-margin services.

Pitch Summary:
EROAD is a New Zealand–based telematics software company with over 90% market share in road user charging within its home market and has been a portfolio position since inception. We bought the stock at NZD 0.92 per share at a market capitalization of NZD 170M and an enterprise value of NZD 198.4M, implying a valuation of only 1.1x EV/sales. At the time, a series of disappointing events, including cost overruns in R&D and an overvalued acquisition, had led to a share price decline of roughly 90% from its 2021 peak. When we discovered the stock, the company was still losing money, but profitability seemed achievable within 6–18 months. We anticipated normalized operating margins of 20–25% and meaningful upside from a rerating once profitability returned. After reporting its first profitable year since 2021, the stock rose sharply, supported by regulatory momentum around mandatory electronic road user charging. However, following the loss of a major U.S. customer and management’s decision to continue subsidizing a sub-scale U.S. business, the stock declined materially and we exited the position.

BSD Analysis:
EROAD sells fleet telematics that turn vehicle data into compliance, safety, and cost savings. Once installed, ripping it out rarely makes economic sense. Growth slowed as customers tightened budgets, testing patience. But regulatory and fuel-efficiency pressures remain structural. Software margins improve as scale builds. Investors dismiss EROAD as niche and regional. That underestimates the stickiness of fleet workflows. If churn stays low, operating leverage emerges quickly. This is IoT SaaS for unsexy assets — and that’s a feature.

Pitch Summary:
Topicus Inc is a compelling investment due to its focus on vertical market software solutions. The recent purchase below the target price highlights its undervaluation and potential for appreciation. The company's strategic acquisitions and market positioning support a bullish outlook. Topicus Inc's ability to deliver specialized software solutions positions it well for growth in niche markets.

BSD Analysis:
The decision to invest in Topicus Inc reflects confidence in its growth strategy and market potential. The company's focus on vertical market software solutions allows it to capture niche opportunities and drive revenue growth. Strategic acquisitions enhance its market presence and competitive advantage. The investment aligns with a long-term strategy focused on quality and value creation. Overall, Topicus Inc's strong fundamentals and market positioning make it an attractive addition to the portfolio.